⚖️ De-escalation in definitive #cervical cancer surgery aims to preserve survival while reducing morbidity. ✨ Simple hysterectomy in selected tumors 🧭 Sentinel node mapping 🔬 Intra-operative tailoring 🎯 Pre-operative brachytherapy @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 🔗 bit.ly/4lCXs9E #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

An also Merry Christmas and Happy holidays from ENYGO Scientific Committee:))

Life project 💪 #education #esgosociety

Our Congress delegates say that one of the features they most look forward to are our Tumour Board sessions, where multidisciplinary teams of experts review real-world patient cases & discuss the most effective diagnostic, treatment, & management strategies for complex cancer cases. 🙌 At ESGO 2026 in Copenhagen 🇩🇰, you’ll be able to attend 2 tumour boards, offering a valuable opportunity to observe & engage in high-level decision-making processes & explore various treatment options for difficult cases from our subspecialty. See you there! #ESGO2026 #gynonc #oncoalert

It is our great honor to inform you that LiFE 19 is published! CONGRATULATIONS to all the team who made this possible! This project would not be possible without you! The LiFE Report 19 is available on our website: buff.ly/UDPLpT9 #research #science #esgosociety

🎙️ New #IJGCConversations Episode! 🚨 Radiation alone vs. Chemoradiation in Intermediate Risk #CervicalCancer with @nagustiga and @dviverosc 🎧 Tune in now and stay ahead in #GynOnc! 🔗 bit.ly/43Wmg5b @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_ @MDAndersonnews

📊 Impact Factor Alert! We’re proud to share that #IJGC's #ImpactFactor has increased to 4.7 in the 2024 Journal Citation Reports! 🚀 💥 We’ve also broken into the #Top10 in #Obstetrics&Gynecology, climbing from #11 to #8 📈 And we moved up 1 spot in #Oncology rankings, too! This milestone is thanks to our amazing authors, reviewers, and editorial team. Thank you for driving excellence in women’s health research! 💙 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_ @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada

A new surgical webinar is approaching soon and we would like to invite you to join us. You can apply through ESGO eAcademy, using this link: buff.ly/b7u0yux #webinar #surgery #ovariancancer #esgosociety

🚨Comparing Total Mesometrial Resection (TMMR) and Radical Hysterectomy (RH) in Early Cervical Cancer: Ontogenetic vs Traditional Anatomical Approaches. Prof. David Cibula & Prof. Dr. Henrik Falconer Dr. Nicolò Bizzarri & Dr. David Viveros Link: buff.ly/loUK6PC

Cervical Cancer treatment studies show no survival advantage of chemoradiotherapy over radiotherapy alone. These results support a more selective approach, reducing unnecessary toxicity for patients with intermediate-risk cervical cancer @JAMAOnc 👉 bit.ly/3YC63yO

Excited about our JAMA Oncology study! Adding CHT to RT showed no OS benefit in intermediate-risk cervical cancer, aligning with GOG 263 (#SGO2025). Hope this helps refine guidelines & improve patient care. @dviverosc @headofmelon @NiteckiRoni @RParejaGineOnco @RauhHainMD

Our latest @JAMANetworkOpen study shows a shift toward surgical de-escalation in gynecologic oncology. Had a great chat with @pedroramirez—how can training programs adapt to keep proficiency in complex procedures? @dviverosc @headofmelon @RParejaGineOnco @RauhHainMD

Exceptional GynOnc Congress, featuring renowned international and local experts sharing the latest advancements in the field. A unique opportunity to learn, connect, and innovate. #GCIGO2025 Medellín,Colombia @RParejaGineOnco @ESGO_society @ENYGO_official @IJGConline

Look who’s here ! @pedroramirezMD @AndreasObermair @RParejaGineOnco #G-CIGO2025 Medellín,Colombia. @IJGConline @ENYGO_official @ESGO_society

We had some great discussions about the exciting scientific projects ENYGO members are working on—both ongoing and upcoming. It’s inspiring to see how much amazing work is being done! If you want to hear more, make sure to join us at the ESGO Congress in Rome at ENYGO sessions.

Our 15-year cohort study explores trends in surgical de-escalation in gynecologic oncology. These findings are transforming patient care but raise important questions about the preparation of fellows in surgical training. @headofmelon @dviverosc @RauhHainMD @NiteckiRoni

Excited to share our Green Journal publication! For low-risk #CervicalCancer patients (tumors ≤2 cm), SH showed no compromise in OS in the NCDB. A step forward for less radical approaches. Grateful for the amazing teamwork, particularly with @dviverosc 🤝📚 #GynOnc

Another great TC from ENYGO Social Committee. We are preparing also for ENYGO sessions at ESGO congress so you are welcome to join is in Rome. #esgo2025 #science #education

Look what just arrived! 🤓📕Honored to be part of this incredible project. @pedroramirezMD @RParejaGineOnco @ENYGO_official

#cancer during #pregnancy is associated with severe maternal and neonatal morbidity. Proud of the entire team for this important manuscript! authors.elsevier.com/c/1k7m2… @RauhHainMD @headofmelon @markaclapp @abigailflynt @dviverosc @nagustiga @MDAndersonNews @AJOG_thegray